Oct. 22, 2021

The False Promise of Current Drug Pricing Reforms

Congress promises to lower drug prices. But patients won’t see any cost savings at the pharmacy counter. We sort through the facts and myths of drug pricing, how “middlemen” in the supply chain lead to higher costs and real solutions …

Episode page
Oct. 15, 2021

Chronic Disease + the Next Pandemic with Scott Gottlieb

COVID-19 continues to put the most vulnerable at risk, including the elderly and those with chronic illnesses. At its peak, it filled up hospitals and forced those seeking non-COVID care to postpone critical appointments. To protect patients and...

Episode page
Oct. 8, 2021

Congress + the Debate Right Now Over the Cures of Tomorrow

Patients depend on the research and development cycle to produce innovative, life saving medicines for rare and chronic conditions. But this medical innovation faces hurdles if Congress passes medicare price negotiations within the Build Back Better...

Episode page
Oct. 1, 2021

Patient How-To Guide: Health Policy Advocacy

Numerous health policies are under debate in Congress. As Senators and Representatives hash out drug pricing legislation and more, where are patients in the conversation? Advocate and former Ohio state legislator Randi Clites shares how patients can...

Episode page
Sept. 24, 2021

Biosimilars Can Lower Costs

As Congress continues to debate solutions to lower healthcare costs, biosimilars are a promising option. But uptake of biosimilars has been slow in the U.S., and few patients are seeing direct savings at the pharmacy counter. Brian Lehman, Director of...

Episode page
Sept. 17, 2021

Lawmakers and Chronic Disease Patients

President Biden outlines a new COVID-19 strategy, the U.S. Senate returns to Washington, and the House of Representatives debates prescription drug prices. Hosts Terry Wilcox and Dr. Bob Goldberg break down D.C.’s busy week and what chronic disease...

Episode page
Sept. 10, 2021

Direct Primary Care: Can Subscription Models Save You Money?

Want greater access to your doctor at a lower price? It’s possible through direct primary care. This healthcare solution allows patients to develop personal relationships with their doctors and receive care quicker and cheaper. Three physicians...

Episode page
Sept. 3, 2021

Ovarian Cancer: What Women Need Congress to Do

What can Congress do to aid in the fight against ovarian cancer? If reauthorized, Johanna’s Law would increase funding for ovarian cancer education and awareness programs. Ovarian Cancer Research Alliance’s VP of Policy, Chad Ramsey,...

Episode page
Aug. 27, 2021

Pediatrician on Delta + Back to School

Kids across the country are headed back to school. But as the Delta variant spreads, what should families living with chronic disease know to stay healthy and safe? Pediatrician Dr. Marlene Wust-Smith gives a back-to-school c...

Episode page
Aug. 20, 2021

How Drug Patents Work

What’s the purpose of a patent? In the pharmaceutical industry, it helps manufacturers reinvest in new research and development to improve upon treatments and drugs. It’s a key part of the cycle of developing new treatments. ...

Episode page
Aug. 13, 2021

Rising Costs of Health Insurance

Premiums, deductibles, and copays continue to rise as insurance companies grow fat through mergers and monopolies. Host Terry Wilcox speaks with former insurance executive-turned-advocate Wendell Potter. Together, they explor...

Episode page
Aug. 6, 2021

Pink Socks + Accelerated Approval for Drugs

The Delta variant, a breakdown of the FDA’s accelerated approval process, and how pink socks are bringing together patient advocacy groups. Hosts Dr. Bob Goldberg and guest host Kate Pecora dive into the news of the week, inc...

Episode page
July 30, 2021

Balanced Approach to Opioids

Opioid overdoses are rising as the COVID-19 pandemic continues. In 2020, overdose deaths rose by 30%. However, many chronic disease patients rely on prescription opioids for their healthcare regimen. We examine a balanced pol...

Episode page
July 23, 2021

Alzheimer’s Drug Debate

The high price tag for a new Alzheimer’s drug has fueled the ongoing drug price debate. But will patients really pay sticker price? (Spoiler alert: No!). Co-host Dr. Bob Goldberg explains the research/value assessment of the ...

Episode page
July 16, 2021

Take Control of Your Health Data

Access to all of your health data - MRIs, screenings, and lab results - could be right at your fingertips. COVID-19 put healthcare tech companies into high gear to deliver health data to patients. The end result? Empowered pa...

Episode page
July 9, 2021

Is Your Medical Equipment Safe?

Patients depend on safety and accuracy of medical equipment. If they’re improperly repaired, it could derail a patient’s healthcare journey and risk their health and safety. The Right to Repair Act aims to expedite medical de...

Episode page
July 2, 2021

Legal Issues with Cancer

Doctor’s visits, tests, procedures and therapies are just one part of a healthcare journey. Knowing and understanding the laws that govern and protect your right to work, along with health insurance coverage and reimbursement...

Episode page
June 25, 2021

Crash Course: FDA Advisory Committees

Drama continues to unfold following the FDA’s controversial approval of a new Alzhiemer’s treatment. Members of the FDA’s advisory committee voted against approval, and some members resigned in protest. But how does this impa...

Episode page
June 18, 2021

Hope for Alzheimer’s Patients + Caregivers

A new FDA-approved drug for Alzheimer’s signals a breakthrough in innovation for patients and caregivers, but has raised doubts from some over the price tag and approval process. Confused about what all of this means for you?...

Episode page
June 11, 2021

How to Humanize Healthcare

Following a pandemic that exposed disparities, and failures to patients with chronic disease, now is the time for lawmakers and the industry in the U.S. to rethink its approach to healthcare. On this episode: how to create su...

Episode page
June 4, 2021

Don’t Be Fooled By Some Supplement Ads

Can you tell the difference between an advertising claim and research-backed statistics? For chronic disease patients who take supplements to manage their conditions, this is an ongoing problem. And the Food and Drug Administ...

Episode page
May 28, 2021

Looking for help with Allergies + Asthma?

More than 60 million Americans live with allergies or asthma. COVID-19 brought much needed attention to lung and respiratory challenges, but where do allergy and asthma patients go now in this emerging post-pandemic world? To...

Episode page
May 21, 2021

Fighting for Mental Health Help

Demands for mental and behavioral health services are on the rise. These services represented nearly half of all telehealth claims during the pandemic, but the digital divide and lack of in-network mental health providers cre...

Episode page
May 14, 2021

Patents and Accelerated Approval for Drugs

When it comes to saving a buck, rare and chronic disease patients are too often put on the chopping block. Accelerated approval drugs are key to treating life threatening diseases. So why is Medicaid and CHIP Payment and Acce...

Episode page